BPA for lumryz
Active Awarded Last action
- Contract number
- 36E79726A0011
- Awardee
-
Avadel CNS Pharmaceuticals, LLC UEI L6XLUBSCA6T5
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 67% complete
- IDV ceiling
- $7,500,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Avadel CNS Pharmaceuticals, LLC (doing business as Avadel Pharmaceuticals) has been awarded a single-award Blanket Purchase Agreement valued at $7.5 million by the National Acquisition Center for the procurement of LUMRYZ, a pharmaceutical product for the federal healthcare market. The contract was awarded on February 13, 2026, with an ultimate completion date of February 12, 2027, and operates under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). As a civilian agency contract, this BPA enables efficient delivery order issuance for pharmaceutical supplies to federal entities, particularly supporting the Department of Veterans Affairs healthcare network. Avadel CNS Pharmaceuticals is a for-profit, foreign-owned pharmaceutical manufacturer specializing in neurological and central nervous system medications, with current System for Award Management registration valid through May 12, 2026.
The contract represents a continuation of Avadel's existing relationship with federal healthcare systems, specifically Veterans Integrated Service Networks, where the company has established a track record of supplying specialized pharmaceutical products through firm fixed-price delivery orders. LUMRYZ, the primary product under this agreement, addresses pharmaceutical needs within the VA healthcare system and potentially other federal agencies authorized to utilize this BPA. The blanket purchase agreement structure facilitates streamlined procurement and predictable pricing for pharmaceutical supplies while maintaining the flexibility to issue multiple delivery orders within the $7.5 million ceiling throughout the contract performance period. This arrangement supports the federal government's objective of ensuring reliable access to specialized pharmaceutical products for veterans and beneficiaries of federal healthcare programs.
Quick answers
Who was awarded contract 36E79726A0011?
36E79726A0011 was awarded to Avadel CNS Pharmaceuticals, LLC by National Acquisition Center (Headquarters) on February 13, 2026.
How much is contract 36E79726A0011 worth?
36E79726A0011's own ceiling is $7,500,000.
Who can order from contract 36E79726A0011?
36E79726A0011 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79726A0011 under another contract?
Yes. 36E79726A0011 is a blanket purchase agreement under 36F79725D0095, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79726A0011 competed?
The extent of competition for 36E79726A0011 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV